Williams Announces Quarterly Cash Dividend

TULSA, Okla.--(BUSINESS WIRE)-- Williams’ (NYSE: WMB) board of directors has approved a regular dividend of $0.41 per share, or $1.64 annualized, on the company’s common stock, payable on March 29, 2021, to holders of record at the close of business on March 12, 2021.

This is a 2.5% increase from Williams’ first-quarter 2020 quarterly dividend of $0.40 per share, paid in March 2020.

Some portion of this distribution may be considered a return of capital for tax purposes. Additional information regarding return of capital distributions is available at Williams’ investor relations website.

Williams has paid a common stock dividend every quarter since 1974.

About Williams

Williams (NYSE: WMB) is committed to being the leader in providing infrastructure that safely delivers natural gas products to reliably fuel the clean energy economy. Headquartered in Tulsa, Oklahoma, Williams is an industry-leading, investment grade C-Corp with operations across the natural gas value chain including gathering, processing, interstate transportation and storage of natural gas and natural gas liquids. With major positions in top U.S. supply basins, Williams connects the best supplies with the growing demand for clean energy. Williams owns and operates more than 30,000 miles of pipelines system wide – including Transco, the nation’s largest volume and fastest growing pipeline – and handles approximately 30 percent of the natural gas in the United States that is used every day for clean-power generation, heating and industrial use. www.williams.com

Portions of this document may constitute “forward-looking statements” as defined by federal law. Although the company believes any such statements are based on reasonable assumptions, there is no assurance that actual outcomes will not be materially different. Any such statements are made in reliance on the “safe harbor” protections provided under the Private Securities Reform Act of 1995. Additional information about issues that could lead to material changes in performance is contained in the company’s annual and quarterly reports filed with the Securities and Exchange Commission.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210126005894/en/

MEDIA:
[email protected]
(800) 945-8723

INVESTOR CONTACTS:
Danilo Juvane
(918) 573-5075

Source: Williams

You May Also Be Interested In

• Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026
• Uniting for Shared Growth, Linking the World: 2026 FHC Future Health Industry Conference Successfully Held in Hangzhou
• IMFINZI® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trial